Medication: Awigli (icodec, insulin)
Indications: diabetes
Development company: Novo Nordisk
Medication: CagriSema
Indications: obesity, type 2 diabetes
Development company: Novo Nordisk
Medication: Cobenfy (Xanomiline and Trospium chloride, also known as KarXT)
Indication: Schizophrenia
Development company: Bristol Myers Squibb
Medication: Ebglyss(lebrikizumab)
Indications: Moderate to severe atopic dermatitis
Development company: Eli Lilly and Company
Medication: Fitusiran
Indications: Hemophilia A and Hemophilia B
Development company: Alnylam Pharmaceuticals, Sanofi
Medication: GSK-3536819(MenABCWY)
Indication: Invasive meningococcal disease
Development company: GSK
Medication: Imdelltra(tarlatamab)
Indication: Small cell lung cancer (SCLC)
Development company: Amgen
Medication: mRESVIA(mRNA-1345)
Indication: Respiratory syncytial virus (RSV) infection
Development company: Moderna
Medication: SEL-212
Indication: Gout
Development company: Selecta Biosciences,Sobi
Medication: Vepdegestrant(ARV-471,PF-07850327)
Indications: advanced breast cancer
Development companies: Arvinas and Pfizer
Medication: Zanzalintinib
Indications: Renal cell carcinoma (RCC), colorectal cancer (CRC), head and neck squamous cell carcinoma (SCCHN)
Development company: Exelixis
<Reprinted from WuXi AppTec>
